CoChat

Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model

Open access
Nguyen, Trent, Hamby, Aaron, Massa, Stephen M. · 2005 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

In investigating the role of metal ions in the pathogenesis of Huntington's disease, we examined the effects of clioquinol, a metal-binding compound currently in clinical trials for Alzheimer's disease treatment, on mutant huntingtin-expressing cells. We found that PC12 cells expressing polyglutamine-expanded huntingtin exon 1 accumulated less mutant protein and showed decreased cell death when treated with clioquinol. This effect was polyglutamine-length-specific and did not alter mRNA levels or protein degradation rates. Clioquinol treatment of transgenic Huntington's mice ( R6 / 2 ) improved behavioral and pathologic phenotypes, including decreased huntingtin aggregate accumulation, decreased striatal atrophy, improved rotarod performance, reduction of weight loss, normalization of blood glucose and insulin levels, and extension of lifespan. Our results suggest that clioquinol is a candidate therapy for Huntington's disease and other polyglutamine-expansion diseases.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0502177102

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 54 references

Research works printed but not linked: 3

  1. Perez, P., Flores, A., Santamaria, A., Rios, C. & Galvan-Arzate, S. (1996) Arch. Med. Res. 27, 449-452.8987176
  2. Maksimovic, I. D., Jovanovic, M. D., Colic, M., Mihajlovic, R., Micic, D., Selakovic, V., Ninkovic, M., Malicevic, Z., Rusic-Stojiljkovic, M. & Jovicic, A. (2001) Vojnosanit Pregl. 58, 237-242.11548547
  3. Ogata, M., Watanabe, S., Tateishi, J., Kuroda, S. & Otsuki, S. (1973) Lancet 1, 1248-1249.

Cited by

Metadata

Authors
Nguyen, T., Hamby, A., & Massa, S. M.
Affiliations
San Francisco VA Medical Center (US)
Venue
Proceedings of the National Academy of Sciences
Published
2005-08-08
Volume
102
Issue
33
Pages
11840-11845
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2009252276
Cited by
194
References
54
Citations by year
2026: 3 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 8 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 10 · 2017: 8 · 2016: 8 · 2015: 13 · 2014: 14 · 2013: 10 · 2012: 14
FWCI
4.35
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Keywords
clioquinol, Huntington's disease, mutant huntingtin, polyglutamine expansion, metal ions, huntingtin aggregates, striatal atrophy, R6/2 transgenic mice, neuroprotection, lifespan extension
MeSH terms
Huntingtin Protein, Animals, Behavior, Animal, Blood Glucose, Body Weight, Cell Line, Disease Models, Animal, Female, Humans, Huntington Disease, Insulin, Clioquinol, Male, Mice, Transgenic, Mutation, Nerve Tissue Proteins, Nuclear Proteins, Pancreas, Peptides, RNA, Messenger, Down-Regulation, Survival Rate, Cell Death, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.